financetom
Business
financetom
/
Business
/
WhiteWater, partners to move forward with Blackcomb pipeline construction
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WhiteWater, partners to move forward with Blackcomb pipeline construction
Jul 31, 2024 3:51 PM

July 31 (Reuters) - Privately held infrastructure firm

WhiteWater and its partners have decided to move forward with

the construction of the Blackcomb Pipeline natural gas pipeline

in Texas, the company said on Wednesday.

The pipeline is expected to transport up to 2.5 billion

cubic feet per day (Bcfpd) of natural gas through about 365

miles from the Permian Basin in West Texas to Agua Dulce in

South Texas.

WhiteWater, MPLX ( MPLX ) and Enbridge ( ENB ) through WPC,

their joint venture that owns the Whistler Pipeline, reached a

final investment decision with an affiliate of Targa Resources ( TRGP )

on the construction.

A shortage in pipeline capacity has plagued natural gas

producers in the Permian who have resorted to flaring to deal

with the excess gas.

The Blackcomb Pipeline will be constructed and operated by

WhiteWater and is expected to be in service in the second half

of 2026, subject to regulatory approvals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Benchmark Electronics Insider Sold Shares Worth $1,101,600, According to a Recent SEC Filing
Benchmark Electronics Insider Sold Shares Worth $1,101,600, According to a Recent SEC Filing
Nov 7, 2024
11:36 AM EST, 11/07/2024 (MT Newswires) -- Jeff Benck, Director, President and CEO, on November 05, 2024, sold 24,000 shares in Benchmark Electronics ( BHE ) for $1,101,600. Following the Form 4 filing with the SEC, Benck has control over a total of 424,173 shares of the company, with 424,173 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/863436/000095017024122956/xslF345X05/ownership.xml Price: 52.01, Change: +0.60,...
Stellantis Collaborating With Infineon on Electric Vehicle Power Architecture
Stellantis Collaborating With Infineon on Electric Vehicle Power Architecture
Nov 7, 2024
10:48 AM EST, 11/07/2024 (MT Newswires) -- Stellantis ( STLA ) and Infineon Technologies said Thursday that they have agreed to work together on the power architecture that will support Stellantis' ( STLA ) electric vehicles. The companies said they signed signed major supply and capacity agreements as part of the collaboration, covering Infineon's PROFET smart power switches, AURIX microcontrollers,...
U.S. FDA proposes ending use of popular decongestant present in cold medicines
U.S. FDA proposes ending use of popular decongestant present in cold medicines
Nov 7, 2024
Nov 7 (Reuters) - The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective, the health regulator said on Thursday. Phenylephrine is widely used in a variety of over-the-counter flu and cold medicines, including popular products...
Pieris Pharmaceuticals' Merger Target Palvella Doses First Patient in Phase 3 Trial of Lymphatic Drug
Pieris Pharmaceuticals' Merger Target Palvella Doses First Patient in Phase 3 Trial of Lymphatic Drug
Nov 7, 2024
11:48 AM EST, 11/07/2024 (MT Newswires) -- Pieris Pharmaceuticals' ( PIRS ) merger target Palvella Therapeutics dosed the first patient in the phase 3 trial of QTORIN 3.9% rapamycin anhydrous gel, a treatment for microcystic lymphatic malformations. Microcystic LMs is a rare genetic disease where abnormal lymph vessels leak fluid and bleed, causing frequent infections and skin problems. The main...
Copyright 2023-2026 - www.financetom.com All Rights Reserved